Anita Vedel Christiansen

Author

Also Known As

A. Christiansen, A. V. Christiansen, A.V. CHRISTIANSEN, A.V. Christiansen, Anita V. Christiansen, Anita Vedel Christiansen, Ludwig Merker

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Boehringer Ingelheim (Denmark)Boehringer Ingelheim (United States)Boehringer Ingelheim (France)Sahlgrenska University Hospital

About

Anita Vedel Christiansen is an author at Boehringer Ingelheim (Germany) specializing in pharmacotherapy, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1.2K
2	Diabetes	2	2	184
3	Pharmacology	2	2	184
4	Orthopaedics	1	1	983
5	Hematology	1	1	983

Anita Vedel Christiansen

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial Bengt I. Eriksson, O.E. Dahl, Nadia Rosencher, Journal of Thrombosis and Haemostasis Total Knee ReplacementThrombosisVenous DiseaseOral Dabigatran EtexilateVenous Thrombosis	2007	983
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Sam Schulman, Ajay K. Kakkar, Samuel Z. Goldhaber, Circulation	2013	923
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus Christopher S. Kovács, Veeraswamy Seshiah, Ludwig Merker, Clinical Therapeutics Diabetes ManagementMedicineInsulin ManagementDiabetesType 2	2015	109
A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II) Sam Schulman, Ajay K. Kakkar, Sebastian Schellong, Blood	2011	93
Empagliflozin as add‐on to metformin in people with Type 2 diabetes Ludwig Merker, H.-U. Häring, Anita Vedel Christiansen, Diabetic Medicine	2015	75
Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes Hans-Ulrich Haering, Ludwig Merker, Anita Vedel Christiansen, Diabetes Research and Clinical Practice Metabolic SyndromeDiabetes ManagementMedicineInsulin ManagementDiabetes	2015	75
A New Oral Aniticoagulant, Dabigatran Etexilate, Is Effective and Safe in Preventing Venous Thromboembolism after Total Knee Replacement Surgery (The RE-MODEL Trial). Bengt I. Eriksson, Ola E. Dahl, C. N. van Dijk, Blood	2006	14

Page 1